CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

adjuvant tislelizumab and chemotherapy for MRD+ patients - Phase 2 | BGNE Pipeline | CatalystAlert